Skip to search formSkip to main contentSkip to account menu

efinaconazole

Known as: (2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol, (2R,3R)-2-(2,4-difluorofenil)-3-(4-metilenopiperidin-1-il)-1-(1h-1,2,4-triazin-1-il)butan-2-ol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
References 1. Liao RX, Lyu XF, Tang WJ, Gao K. Shortand long-term outcomes with renin-angiotensin-aldosterone inhibitors in renal… 
2017
2017
An Efinaconazole preparation method, a crystal form M of Efinaconazole, and a crystal form M preparation method. The… 
2017
2017
The invention discloses a liquid phase analysis method of efinaconazole optical isomers. The stationary phase of liquid… 
2016
2016
建立了高效液相色谱法测定艾氟康唑中的4种光学异构体.采用Daicel Chiralpak IC手性柱,流动相为正己烷:乙醇(85∶15),检测波长210 nm.结果4种光学异构体均在0.5~120 μg/ml范围内线性关系良好,回收率≥99.2%,RSD<1… 
2015
2015
The present invention provides crystalline forms of efinaconazole and processes for their preparation. The invention provides… 
2015
2015
The invention provides a synthetic method of an efinaconazole intermediate. In a reactive solvent, a chemical compound (2) is… 
2015
2015
The present invention provides a process for preparing crystalline forms of efinaconazole and these. The present invention may be… 
2014
2014
The invention discloses a preparation method of efinaconazole (I). The preparation method comprises the following steps… 
2014
2014
The present invention efinaconazole include butylated hydroxy toluene, salts of ethylenediaminetetraacetic acid, and optionally… 
2014
2014
The present invention provides a composition containing a salt, citric acid and any of the epi Tamara najol, the butylated…